Catalent (CTLT) Tops Q3 EPS by 2c, Offers FY Guidance

Go back to Catalent (CTLT) Tops Q3 EPS by 2c, Offers FY Guidance

Catalent, Inc. Reports Third Quarter Fiscal 2020 Results

May 5, 2020 7:28 AM EDT

Q3'20 revenue of $760.6 million increased 23% as-reported, or 25% in constant currency, from Q3'19. Solid organic revenue growth in all four segments. Reporting net debt leverage of 3.8x as of March 31 vs 4.2x at December 31, 2019; more than $600 million in cash and cash equivalents on-hand; growth capital projects continue on schedule. Completed the acquisition of MaSTherCell, a technology-focused cell and gene therapy development and manufacturing partner, on February 10, 2020. Revising FY'20 financial guidance range modestly to reflect fluid COVID-19 situation; long-term fundamentals remain... More